Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
466.5 DKK | +4.83% |
|
+17.41% | +256.00% |
05-07 | Gubra A/S Announces Management Changes | CI |
04-17 | Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.04B | - | - | - | - | - | |
122B | ||||||
116B | ||||||
27.03B | - | |||||
20.36B | - | |||||
15.91B | - |
- Stock Market
- Equities
- GUBRA Stock
- Charts Gubra A/S
- Sector Chart